Rituximab therapy for patients with newly diagnosed, asymptomatic advanced-stage follicular grade I non-Hodgkin's lymphoma (NHL): A phase II trial in the North Central Cancer Treatment Group (NCCTG).

被引：0
|
作者：
Witzig, TE
Vukov, AM
Habermann, TM
Geyer, S
Friedenberg, WR
White, WL
Salim, M
Flynn, PJ
Fitch, TR
Morton, RF
机构：
[1] Mayo Clin, Rochester, MN USA
[2] OHACI, Peoria, IL USA
[3] Guthrie Clin, Milan, Italy
[4] Allan Blair Canc Ctr, Regina, SK, Canada
[5] Oncolog Consultants PA, Minneapolis, MN USA
[6] Mayo Clin, Scottsdale, AZ USA
[7] Iowa Oncol Res Assoc CCOP, Med Oncol & Med Assoc, Des Moines, IA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1398
引用
收藏
页码：361A / 361A
页数：1
相关论文
共 50 条
  • [1] Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: A phase II trial in the north central cancer treatment group
    Witzig, TE
    Vukov, AM
    Habermann, TM
    Geyer, S
    Kurtin, PJ
    Friedenberg, WR
    White, WL
    Chalchal, HI
    Flynn, PJ
    Fitch, TR
    Welker, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1103 - 1108
  • [2] Salvage chemotherapy with rituximab DHAP (RDHAP) for relapsed non-Hodgkin lymphoma (NHL): A phase II trial in the North Central Cancer Treatment Group.
    Witzig, T. E.
    Geyer, S. M.
    Kurtin, P. J.
    Colgan, J. P.
    Inwards, D. J.
    Micallef, I. N.
    Michalak, J. C.
    Salim, M.
    Nikcevich, D. A.
    Dakhil, S. R.
    Fitch, T. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 440S - 440S
  • [3] Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group
    Witzig, Thomas E.
    Geyer, Susan M.
    Kurtin, Paul J.
    Colgan, Joseph P.
    Inwards, David J.
    Micallef, Ivana N. M.
    LaPlant, Betsy R.
    Michalak, John C.
    Salim, Muhammad
    Dalton, Robert J.
    Moore, Dennis F., Jr.
    Reeder, Craig B.
    LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1074 - 1080
  • [4] Phase II study of dulanermin plus rituximab in patients with relapsed follicular non-Hodgkin's lymphoma (NHL).
    Belada, D.
    Mayer, J.
    Czuczman, M. S.
    Flinn, I. W.
    Durbin-Johnson, B.
    Bray, G. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Subcutaneous interleukin-4 for relapsed non-Hodgkin's lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
    Kurtz, D. M.
    Tschetter, L. K.
    Allred, J. B.
    Geyer, S. M.
    Kurtin, P. J.
    Putnam, W. D.
    Rowland, K. M.
    Wiesenfeld, M.
    Soori, G. S.
    Tenglin, R. C.
    Bernath, A. M.
    Witzig, T. E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) : S362 - S362
  • [6] A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance)
    Martin, P.
    Jung, S-H
    Pitcher, B.
    Bartlett, N. L.
    Blum, K. A.
    Shea, T.
    Hsi, E. D.
    Ruan, J.
    Smith, S. E.
    Leonard, J. P.
    Cheson, B. D.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2806 - 2812
  • [7] Phase I/II trial of clofarabine in refractory and/or relapsed non-Hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Bitran, J. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 243 - 243
  • [8] Phase I/II Trial of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    Kallam, Avyakta
    Meza, Jane
    Bierman, Philip
    Lunning, Matthew A.
    Bociek, R. Gregory
    Armitage, James Olen
    Vose, Julie M.
    BLOOD, 2017, 130
  • [9] Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin lymphoma (NHL)
    Reiter, A.
    Meinhardt, A.
    Burkhardt, B.
    Zimmermann, M.
    Borkhardt, A.
    Kontny, U.
    Mann, G.
    Schrappe, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : CP50 - CP50
  • [10] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345